Reference
Price D, et al. LATE-BREAKING ABSTRACT: Cost-effectiveness of the LABA/LAMA dual bronchodilator QVA149 in a Swedish setting. 23rd Annual Congress of the European Respiratory Society : abstr. P280, 7 Sep 2013. Available from: URL: https://www.ersnetsecure.org/public/prg%5fcongres.abstract?ww%5fi%5fpresentation=65498
Rights and permissions
About this article
Cite this article
Glycopyrrolate/indacaterol good choice for COPD. PharmacoEcon Outcomes News 687, 5 (2013). https://doi.org/10.1007/s40274-013-0715-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0715-9